Ying Chen
20Patents
5h-index
15Co-inventors
62Inventor score
Filing activity: Jul 31, 2009 → Jan 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8778305B2 | PSMA-binding agents and uses thereof | Emerging Cross-Sectional Technologies | 75 | Active |
| US9226981B2 | PSMA-binding agents and uses thereof | Emerging Cross-Sectional Technologies | 46 | Active |
| US9056841B2 | PSMA-targeting compounds and uses thereof | Physics | 44 | Active |
| US9861713B2 | PSMA-binding agents and uses thereof | Emerging Cross-Sectional Technologies | 7 | Active |
| US10500292B2 | PSMA-binding agents and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US10232058B2 | Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy | Chemistry; Metallurgy | 5 | Active |
| US10683272B2 | Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy | Human Necessities | 5 | Active |
| US10306895B2 | Plant defense signaling peptides and applications thereof | Human Necessities | 4 | Active |
| US10736974B2 | Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy | Human Necessities | 4 | Active |
| US11021450B2 | PSMA targeted fluorescent agents for image guided surgery | Physics | 2 | Active |
| US11661402B2 | PSMA-targeting compounds and uses thereof | Physics | 1 | Active |
| US10947197B2 | Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyL | Emerging Cross-Sectional Technologies | 1 | Active |
| US11078166B2 | Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11851407B2 | Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPYL | Emerging Cross-Sectional Technologies | 0 | Active |
| US11363822B2 | Plant defense signaling peptides and applications thereof | Human Necessities | 0 | Active |
| US11911488B2 | Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy | Human Necessities | 0 | Active |
| US12070513B2 | PSMA-binding agents and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12291729B2 | Engineered Cas protein and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12065413B2 | PSMA targeted fluorescent agents for image guided surgery | Physics | 0 | Active |
| US11814365B2 | PSMA targeted fluorescent agents for image guided surgery | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.